EE: Physical Activity (2013-2014)
Williamson DL, Kirwan JP. A single bout of concentric resistance exercise increases basal metabolic rate 48 hours after exercise in healthy 59- to 77-year-old men. Gerontol A Biol Sci Med Sci. 1997 Nov; 52(6): M352-M355.
- Steady state: Not defined
- Concentric phase: Allowing only positive work on the bench press, or with each leg and test supervisors lower the weight to minimize eccentric work.
Understand and give written consent
Passed a medical exam (including CBC and urine chemistry, 75gm oral glucose tolerance test), ECG and resistance exercise stress test
Free of chronic infection or disease
- Refusal to consent
- Not meeting inclusion criteria.
Slept in facility for three days to familiarize with procedures and diet; pre-screening test determined an individual’s three repetition maximum (3RM) by graded design.
- Height measured? Yes
- Weight measured? Yes
- Fat-free mass measured? Hydrostatic weighing.
- Monitored heart rate? Not specified
- Body temperature? No
- Medications administered? Excluded.
Resting Energy Expenditure
- IC type: Plexi-glass hood with Hartmann-Braun analyzer
- Equipment of Calibration: Yes
- Coefficient of variation using std gases: No
- Rest before measure (state length of time rested if available): Sedentary conditions
- Measurement length: 15 minutes
- Steady state: Not specified
- Fasting length: Yes, overnight
- Exercise restrictions XX hours prior to test? Yes. Exercise monitored during three-day pre-trial stay and overnight stay prior to BMR measure in General Clinical Research Center
- Room temperature: 22°C±1°C
- Number of measures within the measurement period: One
- Were some measures eliminated? Not specified
- Were a set of measurements averaged? One 30-minute continuous measure
- Coefficient of variation in subjects measures? No
- Training of measurer? Likely
- Subject training of measuring process? Yes.
Eucaloric diet (60% CHO, 15% protein, 25% fat) to maintain energy balance; devoid of caffeine and alcohol. Total calories provided based on Harris-Benedict equation. Food consisted of normal foods plus Ensure liquid supplemental formula.
Outcome(s) and Other Measures
- Measured REE [(VO2, L per minute), VCO2 (L per minute; ml per kg per minute), RQ, ventilation (L per minute)]
- Blood sampling, including plasma insulin and metabolites
- Independent variables of weight, height, age, BMI fat-free mass and fat mass.
- Subjects: N=12 older healthy males, aged 59 to 77 years (mean 66.5±5.0 SE)
- Range: 27 to 34 years.
Mean±SE; paired T-test analysis to test for differences in BMR between control (no exercise) and the exercise trial; P<0.01 were significant.
|Men (± SE)||Mean|
|Body fat, percent||23.4±4.3|
Concentric Exercise Results
Average weight lifted during each knee extension was 18kg±4kg and average of 36kg±7kg was bench pressed.
Indirect Calorimetry Results
- The energy expenditure 48 hours after exercise (extrapolated to a 24-hour period) resulted in a 57kcal per 24-hour significant increase (P<0.0002) in expenditure compared to control (1,570kcal±193kcal per 24 hours vs. 1,627kcal±193kcal per 24 hours, respectively); corresponding to a 3% increase in VO2. No differences between RER.
- Group mean baseline VO2 consumption was 0.225L±0.3L 02 per minute and 48-hour post-exercise measure was 0.232L±0.3L 02 per minute.
- Principal finding of this study was that an acute bout of concentric resistance exercise caused a 3% increase in BMR among a group of healthy 59- to 77-year-old men 48 hours after the exercise bout
- The present study was a duration of –90 minutes [Analyst note: Hard to tell if minus sign (-) or approximate (~) sign.] which has been shown to be sufficient to deplete glycogen stores in concentrically exercised muscle; however, with adequate carbohydrate intake (60% of diet), muscle glycogen would have been replenished and normalized within 48 hours after exercise
- Based on our observations, it would appear that up to 50% of the increase in metabolic rate attributed to resistance training may be due to the residual effects of the last exercise bout, at least among older healthy men.
|University/Hospital:||College of Health and Human Development, Pennsylvania State University|
- Extensive screening criteria to ensure study subjects free from selection bias
- Controlled for kcal content of dietary intake on RMR measurement days
- Three-day training at clinical research center to familiarize with test
- Generalizable to non-obese and healthy older adult males
- Convenience sampling bias
- RMR measurement accuracy did not clearly define steady state or quantify rest after being transported to measure site and did not specify if any time elapsed from resistance exercise before measurement began
- Extrapolation of one 30-minute measure to 24-hour period without use of steady state during the measurement introduces caution in application as increase may not entirely reflect a post-exercise increase.
Quality Criteria Checklist: Primary Research
|1.||Would implementing the studied intervention or procedure (if found successful) result in improved outcomes for the patients/clients/population group? (Not Applicable for some epidemiological studies)||Yes|
|2.||Did the authors study an outcome (dependent variable) or topic that the patients/clients/population group would care about?||Yes|
|3.||Is the focus of the intervention or procedure (independent variable) or topic of study a common issue of concern to dieteticspractice?||Yes|
|4.||Is the intervention or procedure feasible? (NA for some epidemiological studies)||Yes|
|1.||Was the research question clearly stated?||Yes|
|1.1.||Was (were) the specific intervention(s) or procedure(s) [independent variable(s)] identified?||N/A|
|1.2.||Was (were) the outcome(s) [dependent variable(s)] clearly indicated?||N/A|
|1.3.||Were the target population and setting specified?||N/A|
|2.||Was the selection of study subjects/patients free from bias?||Yes|
|2.1.||Were inclusion/exclusion criteria specified (e.g., risk, point in disease progression, diagnostic or prognosis criteria), and with sufficient detail and without omitting criteria critical to the study?||N/A|
|2.2.||Were criteria applied equally to all study groups?||N/A|
|2.3.||Were health, demographics, and other characteristics of subjects described?||N/A|
|2.4.||Were the subjects/patients a representative sample of the relevant population?||N/A|
|3.||Were study groups comparable?||N/A|
|3.1.||Was the method of assigning subjects/patients to groups described and unbiased? (Method of randomization identified if RCT)||N/A|
|3.2.||Were distribution of disease status, prognostic factors, and other factors (e.g., demographics) similar across study groups at baseline?||N/A|
|3.3.||Were concurrent controls or comparisons used? (Concurrent preferred over historical control or comparison groups.)||N/A|
|3.4.||If cohort study or cross-sectional study, were groups comparable on important confounding factors and/or were preexisting differences accounted for by using appropriate adjustments in statistical analysis?||N/A|
|3.5.||If case control study, were potential confounding factors comparable for cases and controls? (If case series or trial with subjects serving as own control, this criterion is not applicable.)||N/A|
|3.6.||If diagnostic test, was there an independent blind comparison with an appropriate reference standard (e.g., "gold standard")?||N/A|
|4.||Was method of handling withdrawals described?||Yes|
|4.1.||Were follow-up methods described and the same for all groups?||N/A|
|4.2.||Was the number, characteristics of withdrawals (i.e., dropouts, lost to follow up, attrition rate) and/or response rate (cross-sectional studies) described for each group? (Follow up goal for a strong study is 80%.)||N/A|
|4.3.||Were all enrolled subjects/patients (in the original sample) accounted for?||N/A|
|4.4.||Were reasons for withdrawals similar across groups?||N/A|
|4.5.||If diagnostic test, was decision to perform reference test not dependent on results of test under study?||N/A|
|5.||Was blinding used to prevent introduction of bias?||No|
|5.1.||In intervention study, were subjects, clinicians/practitioners, and investigators blinded to treatment group, as appropriate?||N/A|
|5.2.||Were data collectors blinded for outcomes assessment? (If outcome is measured using an objective test, such as a lab value, this criterion is assumed to be met.)||N/A|
|5.3.||In cohort study or cross-sectional study, were measurements of outcomes and risk factors blinded?||N/A|
|5.4.||In case control study, was case definition explicit and case ascertainment not influenced by exposure status?||N/A|
|5.5.||In diagnostic study, were test results blinded to patient history and other test results?||N/A|
|6.||Were intervention/therapeutic regimens/exposure factor or procedure and any comparison(s) described in detail? Were interveningfactors described?||Yes|
|6.1.||In RCT or other intervention trial, were protocols described for all regimens studied?||N/A|
|6.2.||In observational study, were interventions, study settings, and clinicians/provider described?||N/A|
|6.3.||Was the intensity and duration of the intervention or exposure factor sufficient to produce a meaningful effect?||N/A|
|6.4.||Was the amount of exposure and, if relevant, subject/patient compliance measured?||N/A|
|6.5.||Were co-interventions (e.g., ancillary treatments, other therapies) described?||N/A|
|6.6.||Were extra or unplanned treatments described?||N/A|
|6.7.||Was the information for 6.4, 6.5, and 6.6 assessed the same way for all groups?||N/A|
|6.8.||In diagnostic study, were details of test administration and replication sufficient?||N/A|
|7.||Were outcomes clearly defined and the measurements valid and reliable?||No|
|7.1.||Were primary and secondary endpoints described and relevant to the question?||N/A|
|7.2.||Were nutrition measures appropriate to question and outcomes of concern?||N/A|
|7.3.||Was the period of follow-up long enough for important outcome(s) to occur?||N/A|
|7.4.||Were the observations and measurements based on standard, valid, and reliable data collection instruments/tests/procedures?||N/A|
|7.5.||Was the measurement of effect at an appropriate level of precision?||N/A|
|7.6.||Were other factors accounted for (measured) that could affect outcomes?||N/A|
|7.7.||Were the measurements conducted consistently across groups?||N/A|
|8.||Was the statistical analysis appropriate for the study design and type of outcome indicators?||Yes|
|8.1.||Were statistical analyses adequately described and the results reported appropriately?||N/A|
|8.2.||Were correct statistical tests used and assumptions of test not violated?||N/A|
|8.3.||Were statistics reported with levels of significance and/or confidence intervals?||N/A|
|8.4.||Was "intent to treat" analysis of outcomes done (and as appropriate, was there an analysis of outcomes for those maximally exposed or a dose-response analysis)?||N/A|
|8.5.||Were adequate adjustments made for effects of confounding factors that might have affected the outcomes (e.g., multivariate analyses)?||N/A|
|8.6.||Was clinical significance as well as statistical significance reported?||N/A|
|8.7.||If negative findings, was a power calculation reported to address type 2 error?||N/A|
|9.||Are conclusions supported by results with biases and limitations taken into consideration?||Yes|
|9.1.||Is there a discussion of findings?||N/A|
|9.2.||Are biases and study limitations identified and discussed?||N/A|
|10.||Is bias due to study's funding or sponsorship unlikely?||Yes|
|10.1.||Were sources of funding and investigators' affiliations described?||N/A|
|10.2.||Was the study free from apparent conflict of interest?||N/A|